Abstract
Chronic treatment with tolerated doses of 6-mercaptopur-ine causes a reduction of 50% or more in the respiration and anaerobic glycolysis of Sarcoma 180 while it does not impair the metabolic functions in liver and kidney. Succinic dehydrogenase activity of Sarcoma 180 is also impaired by treatment with 6-mercaptopurine, but this effect does not seem to be great enough to account fully for the observed reduction in respiration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
